We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
A real-world experience on dose reduction of ibrutinib in chronic lymphocytic leukemia is reported.
No takes yet. Share an insight, caveat, or question.
Roberta Laureana (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: